1
|
Taylor M, Garner P, Oliver S, Desmond N. Use of qualitative research in World Health Organisation guidelines: a document analysis. Health Res Policy Syst 2024; 22:44. [PMID: 38576035 PMCID: PMC10996230 DOI: 10.1186/s12961-024-01120-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2023] [Accepted: 02/10/2024] [Indexed: 04/06/2024] Open
Abstract
BACKGROUND Guidelines depend on effect estimates, usually derived from randomised controlled trials, to inform their decisions. Qualitative research evidence may improve decisions made but where in the process and the methods to do this have not been so clearly established. We sought to describe and appraise how qualitative research has been used to inform World Heath Organization guidance since 2020. METHODS We conducted a document analysis of WHO guidelines from 2020 to 2022. We purposely sampled guidelines on the topics of maternal and newborn health (MANH) and infectious diseases, as most of the qualitative synthesis to date has been conducted on these topics, likely representing the 'best case' scenario. We searched the in-built repository feature of the WHO website and used standardised search terms to identify qualitative reporting. Using deductive frameworks, we described how qualitative evidence was used to inform guidelines and appraised the standards of this use. RESULTS Of the 29 guidelines, over half used qualitative research to help guide decisions (18/29). A total of 8 of these used qualitative research to inform the guideline scope, all 18 to inform recommendations, and 1 to inform implementation considerations. All guidelines drew on qualitative evidence syntheses (QES), and five further supplemented this with primary qualitative research. Qualitative findings reported in guidelines were typically descriptive, identifying people's perception of the benefits and harms of interventions or logistical barriers and facilitators to programme success. No guideline provided transparent reporting of how qualitative research was interpreted and weighed used alongside other evidence when informing decisions, and only one guideline reported the inclusion of qualitative methods experts on the panel. Only a few guidelines contextualised their recommendations by indicating which populations and settings qualitative findings could be applied. CONCLUSIONS Qualitative research frequently informed WHO guideline decisions particularly in the field of MANH. However, the process often lacked transparency. We identified unmet potential in informing implementation considerations and contextualisation of the recommendations. Use in these areas needs further methods development.
Collapse
Affiliation(s)
- Melissa Taylor
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
| | - Paul Garner
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Sandy Oliver
- EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London, London, UK
- Africa Centre for Evidence, Faculty of Humanities, University of Johannesburg, Johannesburg, South Africa
| | - Nicola Desmond
- Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK
| |
Collapse
|
2
|
Hampton J, Mugambi P, Caggiano E, Eugene R, Valente A, Taylor M, Carreiro S. Closing the Digital Divide in Interventions for Substance Use Disorder. J Psychiatr Brain Sci 2024; 9:e240002. [PMID: 38726224 PMCID: PMC11081399 DOI: 10.20900/jpbs.20240002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2024]
Abstract
Digital health interventions are exploding in today's medical practice and have tremendous potential to support the treatment of substance use disorders (SUD). Developers and healthcare providers alike must be cognizant of the potential for digital interventions to exacerbate existing inequities in SUD treatment, particularly as they relate to Social Determinants of Health (SDoH). To explore this evolving area of study, this manuscript will review the existing concepts of the digital divide and digital inequities, and the role SDoH play as drivers of digital inequities. We will then explore how the data used and modeling strategies can create bias in digital health tools for SUD. Finally, we will discuss potential solutions and future directions to bridge these gaps including smartphone ownership, Wi-Fi access, digital literacy, and mitigation of historical, algorithmic, and measurement bias. Thoughtful design of digital interventions is quintessential to reduce the risk of bias, decrease the digital divide, and create equitable health outcomes for individuals with SUD.
Collapse
Affiliation(s)
- Jazmin Hampton
- Division of Toxicology, Department of Emergency Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA
- Washington University of Health and Science, San Pedro, Belize, Central America
- Division of Public Health, Walden University, Minneapolis, MN 55401, USA
| | - Purity Mugambi
- Manning College of Information and Computer Sciences, University of Massachusetts-Amherst, Amherst, MA 01003, USA
| | - Emily Caggiano
- Division of Toxicology, Department of Emergency Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA
| | - Reynalde Eugene
- Division of Toxicology, Department of Emergency Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA
| | - Alycia Valente
- Division of Toxicology, Department of Emergency Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA
| | - Melissa Taylor
- Division of Toxicology, Department of Emergency Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA
| | - Stephanie Carreiro
- Division of Toxicology, Department of Emergency Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA
| |
Collapse
|
3
|
Taylor M, Medley N, van Wyk SS, Oliver S. Community views on active case finding for tuberculosis in low- and middle-income countries: a qualitative evidence synthesis. Cochrane Database Syst Rev 2024; 3:CD014756. [PMID: 38511668 PMCID: PMC10955804 DOI: 10.1002/14651858.cd014756.pub2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/22/2024]
Abstract
BACKGROUND Active case finding (ACF) refers to the systematic identification of people with tuberculosis in communities and amongst populations who do not present to health facilities, through approaches such as door-to-door screening or contact tracing. ACF may improve access to tuberculosis diagnosis and treatment for the poor and for people remote from diagnostic and treatment facilities. As a result, ACF may also reduce onward transmission. However, there is a need to understand how these programmes are experienced by communities in order to design appropriate services. OBJECTIVES To synthesize community views on tuberculosis active case finding (ACF) programmes in low- and middle-income countries. SEARCH METHODS We searched MEDLINE, Embase, and eight other databases up to 22 June 2023, together with reference checking, citation searching, and contact with study authors to identify additional studies. We did not include grey literature. SELECTION CRITERIA This review synthesized qualitative research and mixed-methods studies with separate qualitative data. Eligible studies explored community experiences, perceptions, or attitudes towards ACF programmes for tuberculosis in any endemic low- or middle-income country, with no time restrictions. DATA COLLECTION AND ANALYSIS Due to the large volume of studies identified, we chose to sample studies that had 'thick' description and that investigated key subgroups of children and refugees. We followed standard Cochrane methods for study description and appraisal of methodological limitations. We conducted thematic synthesis and developed codes inductively using ATLAS.ti software. We examined codes for underlying ideas, connections, and interpretations and, from this, generated analytical themes. We assessed the confidence in the findings using the GRADE-CERQual approach, and produced a conceptual model to display how the different findings interact. MAIN RESULTS We included 45 studies in this synthesis, and sampled 20. The studies covered a broad range of World Health Organization (WHO) regions (Africa, South-East Asia, Eastern Mediterranean, and the Americas) and explored the views and experiences of community members, community health workers, and clinical staff in low- and middle-income countries endemic for tuberculosis. The following five themes emerged. • ACF improves access to diagnosis for many, but does little to help communities on the edge. Tuberculosis ACF and contact tracing improve access to health services for people with worse health and fewer resources (High confidence). ACF helps to find this population, exposed to deprived living conditions, but is not sensitive to additional dimensions of their plight (High confidence) and out-of-pocket costs necessary to continue care (High confidence). Finally, migration and difficult geography further reduce communities' access to ACF (High confidence). • People are afraid of diagnosis and its impact. Some community members find screening frightening. It exposes them to discrimination along distinct pathways (isolation from their families and wider community, lost employment and housing). HIV stigma compounds tuberculosis stigma and heightens vulnerability to discrimination along these same pathways (High confidence). Consequently, community members may refuse to participate in screening, contact tracing, and treatment (High confidence). In addition, people with tuberculosis reported their emotional turmoil upon diagnosis, as they anticipated intense treatment regimens and the prospect of living with a serious illness (High confidence). • Screening is undermined by weak health infrastructure. In many settings, a lack of resources results in weak services in competition with other disease control programmes (Moderate confidence). In this context of low investment, people face repeated tests and clinic visits, wasted time, and fraught social interaction with health providers (Moderate confidence). ACF can create expectations for follow-up health care that it cannot deliver (High confidence). Finally, community education improves awareness of tuberculosis in some settings, but lack of full information impacts community members, parents, and health workers, and sometimes leads to harm for children (High confidence). • Health workers are an undervalued but important part of ACF. ACF can feel difficult for health workers in the context of a poorly resourced health system and with people who may not wish to be identified. In addition, the evidence suggests health workers are poorly protected against tuberculosis and fear they or their families might become infected (Moderate confidence). However, they appear to be central to programme success, as the humanity they offer often acts as a driving force for retaining people with tuberculosis in care (Moderate confidence). • Local leadership is necessary but not sufficient for ensuring appropriate programmes. Local leadership creates an intrinsic motivation for communities to value health services (High confidence). However, local leadership cannot guarantee the success of ACF and contact tracing programmes. It is important to balance professional authority with local knowledge and rapport (High confidence). AUTHORS' CONCLUSIONS Tuberculosis active case finding (ACF) and contact tracing bring a diagnostic service to people who may otherwise not receive it, such as those who are well or without symptoms and those who are sick but who have fewer resources and live further from health facilities. However, capturing these 'missing cases' may in itself be insufficient without appropriate health system strengthening to retain people in care. People who receive a tuberculosis diagnosis must contend with a complex and unsustainable cascade of care, and this affects their perception of ACF and their decision to engage with it.
Collapse
Affiliation(s)
- Melissa Taylor
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Nancy Medley
- Department of Women's and Children's Health, University of Liverpool, Liverpool, UK
| | - Susanna S van Wyk
- Centre for Evidence-based Health Care, Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
| | - Sandy Oliver
- EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London, London, UK
- Faculty of the Humanities, University of Johannesburg, Johannesburg, South Africa
| |
Collapse
|
4
|
Tulleners T, Taylor M, Campbell C. Contribution of peer group supervision to nursing practice: An interpretive phenomenological study. Nurse Educ Pract 2024; 75:103903. [PMID: 38271915 DOI: 10.1016/j.nepr.2024.103903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2023] [Revised: 12/15/2023] [Accepted: 01/16/2024] [Indexed: 01/27/2024]
Abstract
AIM To provide insight into peer group supervision practices through understanding the lived experience of community health nurses. BACKGROUND The recent Covid-19 health crisis highlights the importance of supportive mechanisms to sustain and retain nurses in the workforce. While the support of quality clinical supervision for registered nurses is recognised, the benefits and challenges of peer group supervision are less clearly articulated. DESIGN Nurses' experiences of peer group supervision in an Australian tertiary health service were explored using a Gadamerian philosophical hermeneutic approach. METHOD Semi-structured in-depth interviews were conducted in 2021 and provided nurses with the opportunity to share their experiences of using the New Zealand Coaching and Mentoring Model of peer group supervision. The study included a total of 31 nurse participants across multiple community health contexts. Interview data were analysed using a hermeneutic approach from which themes arose. FINDINGS The findings demonstrated that strong peer group supervision foundations that include personal and professional preparation and active participation are essential. Dual pillars of "the unique individual" and "the unique group" with responsibilities identified in each pillar that enable interactions and worthiness in peer group supervision practice. The foundations and pillars support peer group supervision in nursing practice to provide a mechanism for reflection, support and professional guidance. CONCLUSIONS Peer group supervision is a worthy, contributory process in community health nursing when implementation processes are supported and teams are educated and prepared. Perceptions of peer group supervision are unique and varied across individuals. The individual experience has an impact on the group experience and vice versa. Knowledge of the process and group by participants is required to enable professional reflection through nursing peer group supervision.
Collapse
Affiliation(s)
- Tracey Tulleners
- School of Nursing and Midwifery, University of Southern Queensland, 11 Salisbury Rd, Ipswich 4305, Australia.
| | - Melissa Taylor
- School of Nursing and Midwifery, University of Southern Queensland, 11 Salisbury Rd, Ipswich 4305, Australia; Centre for Health Research, University of Southern Queensland, 11 Salisbury Rd, Ipswich 4305, Australia.
| | - Christina Campbell
- School of Psychology and Wellbeing, University of Southern Queensland, 11 Salisbury Rd, Ipswich 4305, Australia.
| |
Collapse
|
5
|
Taylor M, Heinz E, Gondwe M, Masekela R, Morton B, Oronje R, Vercueil A, Abimbola S, Obasi A. Authorship reflexivity statements: additional considerations. BMJ Glob Health 2024; 9:e014743. [PMID: 38176744 PMCID: PMC10773370 DOI: 10.1136/bmjgh-2023-014743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Accepted: 12/07/2023] [Indexed: 01/06/2024] Open
Affiliation(s)
- Melissa Taylor
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Eva Heinz
- Departments of Clinical Sciences and of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Mtisunge Gondwe
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Refiloe Masekela
- Department of Paediatrics and Child Health, College of Health Sciences University of KwaZulu Natal, Durban, KwaZulu Natal, South Africa
| | - Ben Morton
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Rose Oronje
- African Institute for Development Policy (AFIDEP), Westlands-Nairobi, Kenya
| | - Andre Vercueil
- King's College Hospital NHS Foundation Trust, London, UK
| | - Seye Abimbola
- School of Public Health, University of Sydney, Sydney, New South Wales, Australia
| | - Angela Obasi
- Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK
- AXESS Clinic, Royal Liverpool University Hospital, Liverpool, UK
| |
Collapse
|
6
|
Allali S, Marquant F, Rignault-Bricard R, Taylor M, Brice J, de Montalembert M, Maciel TT, Elie C, Hermine O. Oral famotidine reduces the plasma level of soluble P-selectin in children with sickle cell disease. Br J Haematol 2024; 204:346-351. [PMID: 37722599 DOI: 10.1111/bjh.19111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Revised: 08/30/2023] [Accepted: 09/07/2023] [Indexed: 09/20/2023]
Abstract
Plasma histamine levels are increased in patients with sickle cell disease (SCD), potentially promoting endothelial P-selectin expression and vaso-occlusion via histamine type 2 (H2) receptors. We conducted a prospective, non-comparative, single-centre study to determine whether famotidine, a H2 receptor antagonist, reduces P-selectin expression in SCD children. The median plasma P-selectin level was significantly reduced after 29 days of oral famotidine (53.2 ng/mL [IQR: 46.7-63.4] vs. 69.9 ng/mL [IQR: 53.6-84.2], median difference -10.2 ng/mL [IQR: -21.8 to -2.7], p = 0.005) in 28 patients. No effect was observed on other adhesion molecules, inflammation or haemolysis markers, except decreased reticulocyte count. No adverse events deemed related to famotidine were observed. Randomized controlled trials are now needed to assess the efficacy of famotidine in preventing vaso-occlusion in SCD.
Collapse
Affiliation(s)
- Slimane Allali
- Department of General Paediatrics and Paediatric Infectious Diseases, Sickle Cell Centre, Assistance Publique - Hôpitaux de Paris (AP-HP), Necker-Enfants Malades Hospital, Université Paris Cité, Paris, France
- Laboratory of Cellular and Molecular Mechanisms of Haematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Fabienne Marquant
- Unité de Recherche Clinique/Centre d'investigation Clinique, Necker-Enfants Malades Hospital, AP-HP, Paris, France
| | - Rachel Rignault-Bricard
- Laboratory of Cellular and Molecular Mechanisms of Haematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France
| | - Melissa Taylor
- Department of General Paediatrics and Paediatric Infectious Diseases, Sickle Cell Centre, Assistance Publique - Hôpitaux de Paris (AP-HP), Necker-Enfants Malades Hospital, Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Joséphine Brice
- Department of General Paediatrics and Paediatric Infectious Diseases, Sickle Cell Centre, Assistance Publique - Hôpitaux de Paris (AP-HP), Necker-Enfants Malades Hospital, Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Mariane de Montalembert
- Department of General Paediatrics and Paediatric Infectious Diseases, Sickle Cell Centre, Assistance Publique - Hôpitaux de Paris (AP-HP), Necker-Enfants Malades Hospital, Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Thiago Trovati Maciel
- Laboratory of Cellular and Molecular Mechanisms of Haematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Caroline Elie
- Unité de Recherche Clinique/Centre d'investigation Clinique, Necker-Enfants Malades Hospital, AP-HP, Paris, France
| | - Olivier Hermine
- Laboratory of Cellular and Molecular Mechanisms of Haematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
- Department of Haematology, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France
- Reference Centre for Mastocytosis, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France
| |
Collapse
|
7
|
Haydon HM, Snoswell CL, Jones C, Carey M, Taylor M, Horstmanshof L, Hicks R, Lotfaliany M, Banbury A. Digital health literacy to enhance workforce skills and clinical effectiveness: A response to 'Digital health literacy: Helpful today, dependency tomorrow? Contingency planning in a digital age'. Australas J Ageing 2023; 42:803-804. [PMID: 37986677 DOI: 10.1111/ajag.13257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Revised: 10/26/2023] [Accepted: 10/30/2023] [Indexed: 11/22/2023]
Affiliation(s)
- Helen M Haydon
- Centre for Online Health, University of Queensland, Brisbane, Queensland, Australia
- Centre for Health Services Research, University of Queensland, Brisbane, Queensland, Australia
| | - Centaine L Snoswell
- Centre for Online Health, University of Queensland, Brisbane, Queensland, Australia
- Centre for Health Services Research, University of Queensland, Brisbane, Queensland, Australia
| | - Cindy Jones
- Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland, Australia
- Menzies Health Institute Queensland, Griffith University, Brisbane, Queensland, Australia
| | - Melissa Carey
- Centre for Health Research, The University of Southern Queensland, Ipswich, Queensland, Australia
- University of Auckland, Auckland, New Zealand
| | - Melissa Taylor
- School of Nursing and Midwifery, Centre for Health Research, The University of Southern Queensland, Ipswich, Queensland, Australia
| | - Louise Horstmanshof
- Faculty of Health, Southern Cross University, Lismore, New South Wales, Australia
| | - Richard Hicks
- School of Psychology, Faculty of Society and Design, Bond University, Gold Coast, Queensland, Australia
| | - Mojtaba Lotfaliany
- Centre for Online Health, University of Queensland, Brisbane, Queensland, Australia
- Centre for Health Services Research, University of Queensland, Brisbane, Queensland, Australia
- The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia
| | - Annie Banbury
- Centre for Online Health, University of Queensland, Brisbane, Queensland, Australia
- Centre for Health Services Research, University of Queensland, Brisbane, Queensland, Australia
| |
Collapse
|
8
|
Mayrand L, Tarbé de Saint Hardouin AL, Maciel TT, Rignault-Bricard R, Taylor M, Brice J, de Montalembert M, Hermine O, Greco C, Allali S. Dramatic efficacy of cannabidiol on refractory chronic pain in an adolescent with sickle cell disease. Am J Hematol 2023; 98:E295-E297. [PMID: 37540761 DOI: 10.1002/ajh.27049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Revised: 07/17/2023] [Accepted: 07/21/2023] [Indexed: 08/06/2023]
Abstract
Here, we report a dramatic efficacy of cannabidiol in an adolescent with SCD suffering from chronic pain refractory to other analgesics, with complete regression of chronic pain and rapid plasma histamine level normalization after treatment.
Collapse
Affiliation(s)
- Lara Mayrand
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Department of Pain and Palliative Care Unit, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France
| | | | - Thiago Trovati Maciel
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Rachel Rignault-Bricard
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Melissa Taylor
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Joséphine Brice
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Mariane de Montalembert
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Olivier Hermine
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
- Department of Hematology, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France
- Reference Center for Mastocytosis, Necker-Enfants Malades Hospital, AP-HP, Paris, France
| | - Céline Greco
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France
- Department of Pain and Palliative Care Unit, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France
| | - Slimane Allali
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| |
Collapse
|
9
|
Taylor M, Tapkigen J, Ali I, Liu Q, Long Q, Nabwera H. The impact of growth monitoring and promotion on health indicators in children under five years of age in low- and middle-income countries. Cochrane Database Syst Rev 2023; 10:CD014785. [PMID: 37823471 PMCID: PMC10568659 DOI: 10.1002/14651858.cd014785.pub2] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/13/2023]
Abstract
BACKGROUND Undernutrition in the critical first 1000 days of life is the most common form of childhood malnutrition, and a significant problem in low- and middle-income countries (LMICs). The effects of undernutrition in children aged under five years are wide-ranging and include increased susceptibility to and severity of infections; impaired physical and cognitive development, which diminishes school and work performance later in life; and death. Growth monitoring and promotion (GMP) is a complex intervention that comprises regular measurement and charting of growth combined with promotion activities. Policymakers, particularly in international aid agencies, have differing and changeable interpretations and perceptions of the purpose of GMP. The effectiveness of GMP as an approach to preventing malnutrition remains a subject of debate, particularly regarding the added value of growth monitoring compared with promotion alone. OBJECTIVES To evaluate the effectiveness of child growth monitoring and promotion for identifying and addressing faltering growth, improving infant and child feeding practices, and promoting contact with and use of health services in children under five years of age in low- and middle-income countries. SEARCH METHODS We used standard, extensive Cochrane search methods. The latest search date was 3 November 2022. SELECTION CRITERIA We included randomised controlled trials (RCTs), cohort studies, and controlled before-after studies that compared GMP with standard care or nutrition education alone in non-hospitalised children aged under five years. DATA COLLECTION AND ANALYSIS We used standard Cochrane methods to conduct a narrative synthesis. Our primary outcomes were anthropometric indicators, infant and child feeding practices, and health service usage. Secondary outcomes were frequency and severity of childhood illnesses, and mortality. We used GRADE to assess the certainty of evidence for each primary outcome. MAIN RESULTS We included six studies reported in eight publications. We grouped the findings according to intervention. Community-based growth monitoring and promotion (without supplementary feeding) versus standard care We are unsure if GMP compared to standard care improves infant and child feeding practices, as measured at 24 months by the proportion of infants who have fluids other than breast milk introduced early (49.7% versus 70.5%; 1 study; 4296 observations; very low-certainty evidence). We are unsure if GMP improves health service usage, as measured at 24 months by the proportion of children who receive vitamin A (72.5% versus 62.9%; 1 study; 4296 observations; very low-certainty evidence) and the proportion of children who receive deworming (29.2% versus 14.6%; 1 study; 4296 observations; very low-certainty evidence). No studies reported selected anthropometric indicators (weight-for-age z-score or height-for-age z-score) at 12 or 24 months, infant and child feeding practices at 12 months, or health service usage at 12 months. Community-based growth monitoring and promotion (with supplementary feeding) versus standard care Two studies (with 569 participants) reported the mean weight-for-age z-score at 12 months, providing very low-certainty evidence: in one study, there was little or no difference between GMP and standard care (mean difference (MD) -0.07, 95% confidence interval (CI) -0.19 to 0.06); in the other study, mean weight-for-age z-score worsened in both groups, but we were unable to calculate a relative effect. GMP versus standard care may make little to no difference to the mean height-for-age z-score at 12 months (MD -0.15, 95% CI -0.34 to 0.04; 1 study, 337 participants; low-certainty evidence). Two studies (with 564 participants) reported a range of outcome measures related to infant and child feeding practices at 12 months, showing little or no difference between the groups (very low-certainty evidence). No studies reported health service usage at 12 or 24 months, feeding practices at 24 months, or selected anthropometric indicators at 24 months. AUTHORS' CONCLUSIONS There is limited uncertain evidence on the effectiveness of GMP for identifying and addressing faltering growth, improving infant and child feeding practices, and promoting contact with and use of health services in children aged under five years in LMICs. Future studies should explore the reasons for the apparent limited impact of GMP on key child health indicators. Reporting of GMP interventions and important outcomes must be transparent and consistent.
Collapse
Affiliation(s)
- Melissa Taylor
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | | | - Israa Ali
- Liverpool Heart and Chest Hospital, Liverpool, UK
| | - Qin Liu
- Affiliate of the Cochrane China Network, School of Public Health, Chongqing Medical University, Chongqing, China
| | - Qian Long
- Global Health Research Center, Duke Kunshan University, Kunshan, China
| | - Helen Nabwera
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| |
Collapse
|
10
|
Taylor M, Travis R, Bredel M, Markert JM, Riley K, Willey CD, Fiveash JB. Assessment of Local and Regional Control in Atypical (WHO Grade 2) Meningiomas Receiving Fractioned Stereotactic Radiotherapy. Int J Radiat Oncol Biol Phys 2023; 117:e153. [PMID: 37784739 DOI: 10.1016/j.ijrobp.2023.06.975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The optimal delivery of postoperative radiotherapy to WHO grade 2 or atypical meningiomas (AM) is controversial. The historical standard of care has been high dose fractionated radiation to the resection bed and a 2 cm CTV as in RTOG 0539. Single fraction radiosurgery offers a more conformal alternative with demonstrated local control for smaller AM in less sensitive areas. Though less studied, fractionated stereotactic radiosurgery (FSRT) promises safer treatment of larger AM in more sensitive locations while minimizing the treated volume. This single institution retrospective review examines the hypothesis that local and marginal failure patterns in AM treated with five fraction FSRT remain unacceptably high. MATERIALS/METHODS Thirty-nine patients received 27.5 - 30 Gy in 5 fractions to their AM from 2009 to 2022 with grading based on the WHO criteria active at the time of treatment. All treatments were frameless VMAT deliveries with no PTV margin. Histological diagnosis of AM, gross disease at time of FSRT, five fraction FSRT, and lack of prior local radiation were required for inclusion. Single fraction treatments were excluded. Local recurrence was defined similar to RECIST criteria as an increase of 20% in the greatest cross-sectional diameter on MRI (or CT if MRI contraindicated) with at least one voxel touching the prescription volume. To examine the role of CTV margin, marginal recurrence was defined as any new lesion outside of the prescription volume but within 2 cm of the resection cavity. High grade toxicity per CTCAE v5 was an irreversible grade 3 or any grade 4 toxicity. Resection for radionecrosis was considered a local failure if any viable tumor was seen on pathology. RESULTS Median follow up was 32.5 months (range 3.2-147.5 months). The number of AM treated post STR, post GTR recurrence, and definitively were 26, 16, and 5 respectively. 3-year local tumor control was estimated to be 84%. As expected, larger tumors were more likely to fail locally (p >.001). Two (5%) patients experienced high grade toxicity - both symptomatic radionecrosis requiring resection. Three-year marginal control was estimated to be 92.3%. Of the 5 tumors treated to the entire resection cavity, none experienced a marginal failure. Interestingly, recurrent tumors s/p GTR were more likely to recur marginally than tumors treated after STR (p = .009). Only 1 (4%) tumor treated after STR failed marginally while 4 (33%) tumors treated after GTR recurrence failed. CONCLUSION The rate of high-grade toxicity in AM receiving FSRT was low. Local control appeared comparable to historical rates which may suggest the need for dose escalation with longer term follow-up. Recurrent tumors appear more prone to marginal failures, however more work is needed to determine which patients may benefit from additional CTV margin and more prolonged fractionated dose schedules. Improved targeting with newer imaging studies (e.g., DOTATATE PET) should be examined to determine if more accurate targeting will improve outcomes.
Collapse
Affiliation(s)
- M Taylor
- University of Alabama at Birmingham Department of Radiation Oncology, Birmingham, AL
| | - R Travis
- University of Alabama at Birmingham Department of Radiation Oncology, Birmingham, AL
| | - M Bredel
- University of Alabama at Birmingham Department of Radiation Oncology, Birmingham, AL
| | - J M Markert
- University of Alabama at Birmingham Department of Neurosurgery, Birmingham, AL
| | - K Riley
- University of Alabama at Birmingham Department of Neurosurgery, Birmingham, AL
| | - C D Willey
- University of Alabama at Birmingham Department of Radiation Oncology, Birmingham, AL
| | - J B Fiveash
- University of Alabama at Birmingham Department of Radiation Oncology, Birmingham, AL
| |
Collapse
|
11
|
Gray R, Taylor M, Bullock R. Orthopaedic Out of Bed Project (OOBP): improving early mobilisation following femoral fracture using a therapy-led education programme. BMJ Open Qual 2023; 12:e002301. [PMID: 37783518 PMCID: PMC10565298 DOI: 10.1136/bmjoq-2023-002301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2023] [Accepted: 05/23/2023] [Indexed: 10/04/2023] Open
Abstract
Delayed mobilisation following hip fracture surgery is detrimental to patients and health systems. Prolonged hospital stay additionally results in decreased function and increased mortality. Our hospital was underperforming against the national metric for mobilisation by the day after surgery and physiotherapists were the primary healthcare professionals expected to do this. The therapy team therefore undertook a service improvement to increase the number of patients mobilised by the day after their femoral fracture surgery. This was through a ward-based education programme aimed at increasing confidence and competence of the trauma ward healthcare assistants (HCAs) to complete this task when appropriate instead of physiotherapists.The model for improvement was used, with two Plan-Do-See-Act cycles completed between 2020 and 2022. On completion of the therapy-led intervention, the percentage of patients mobilised by the day after surgery was shown to have increased from a mean average of 60% in 2019 to 79% in 2022. The number of patients mobilised by HCAs prior to physiotherapy assessment increased from 2% prior to and 30% following the intervention.The programme improved HCA confidence and competence using a rehabilitation ethos to mobilise patients following hip fracture surgery. It also showed a clinically significant improvement in the percentage of patients with hip fracture mobilising by the day after surgery and a large increase in the number of patients mobilised by our trauma ward HCAs prior to an initial physiotherapy assessment. This work has demonstrated implications for orthopaedic trauma services and the patients who receive them. It reduces the single point of failure of relying on a physiotherapist to mobilise a patient through increasing multidisciplinary confidence and capability on the ward to perform the task. In turn, this increases physiotherapy capacity to provide acute rehabilitation, which is another important part of femoral fracture recovery.
Collapse
Affiliation(s)
- Rene Gray
- Integrated Therapies Department, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK
| | - Melissa Taylor
- Integrated Therapies Department, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK
| | - Ryan Bullock
- Integrated Therapies Department, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK
| |
Collapse
|
12
|
Shringarpure K, Gurumurthy M, Sagili KD, Taylor M, Garner P, Tonsing J, Rao R, Sachdeva KS. Patient adherence to tuberculosis treatment in the Indian subcontinent: systematic review and meta-synthesis of qualitative research. BMJ Open 2023; 13:e063926. [PMID: 37142319 PMCID: PMC10163483 DOI: 10.1136/bmjopen-2022-063926] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/06/2023] Open
Abstract
OBJECTIVES How well patients adhere to their tuberculosis (TB) treatment influences their recovery and development of drug resistance, but influences on adherence are multiple and often competing. We synthesised qualitative studies from our setting in the Indian subcontinent to understand the dimensions and dynamics involved to help inform service provision. DESIGN Qualitative synthesis comprising inductive coding, thematic analysis and forming a conceptual framework. DATA SOURCES Medline (OVID), Embase (OVID), CINAHL (EBSCOHost), PsycINFO (EBSCOHost), Web of Science Core Collection, Cochrane Library and Epistemonikos were databases searched on 26 March 2020 for studies published since 1 January 2000. ELIGIBILITY CRITERIA FOR SELECTING STUDIES We included reports in English from the Indian subcontinent that used qualitative or mixed-methodology designs and reported findings around adherence to TB treatment. Full texts meeting eligibility were sampled based on 'thickness' (the richness of the qualitative data reported). DATA EXTRACTION AND SYNTHESIS Two reviewers used standardised methods to screen abstracts and code. Included studies were assessed for reliability and quality using a standard tool. Qualitative synthesis was performed by inductive coding, thematic analysis and developing conceptual framework. RESULTS Of 1729 abstracts screened from initial search, 59 were shortlisted for full-text review. Twenty-four studies that qualified as 'thick' were included in the synthesis. Studies were set in India (12), Pakistan (6), Nepal (3), Bangladesh (1) or in two or more of these countries (2). Of the 24 studies, all but one included people who were taking TB treatment (1 study included only healthcare providers), and 17 included healthcare workers, community members or both.We identified three themes: (1) personal influences on the people with TB include interconnections between their social role in the family unit, their own priorities in day-to-day living and their experience to date with the disease; (2) adherence is profoundly influenced by how individual healthcare providers interact with patients on treatment and address their needs; (3) adherence is influenced across communities by structural, social, economic and cultural factors related to treatment. CONCLUSION Staff in TB programmes require an understanding of the various competing influences on individuals undergoing treatment. Programmes need to have more flexible and people-centred approaches to service provision in order to achieve adherence, and thus improve treatment outcomes. PROSPERO REGISTRATION NUMBER CRD42020171409.
Collapse
Affiliation(s)
- Kalpita Shringarpure
- Department of Community Medicine, Medical College Baroda, Baroda, Gujarat, India
| | - Meera Gurumurthy
- Research Division, Vital Strategies, Singapore
- TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India
| | - Karuna D Sagili
- TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India
| | - Melissa Taylor
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Paul Garner
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Jamie Tonsing
- TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India
- The Global Fund to Fight AIDS Tuberculosis and Malaria, Grand-Saconnex, Geneva, Switzerland
| | - Raghuram Rao
- National Tuberculosis Elimination Programme (NTEP), Central TB Division, India Ministry of Health and Family Welfare, New Delhi, India
| | - Kuldeep Singh Sachdeva
- TB Department, International Union Against Tuberculosis and Lung Disease (The Union), South East Asia Office, New Delhi, India
- National Tuberculosis Elimination Programme (NTEP), Central TB Division, India Ministry of Health and Family Welfare, New Delhi, India
| |
Collapse
|
13
|
Allali S, Elie J, Mayrand L, de Montalembert M, Taylor M, Brice J, Maire A, Rignault-Bricard R, Heilbronner C, Cohen JF, Maciel TT, Hermine O. Sputum IL-6 level as a potential predictor of acute chest syndrome during vaso-occlusive crisis in children with sickle cell disease: Exploratory prospective prognostic accuracy study. Am J Hematol 2023. [PMID: 37096490 DOI: 10.1002/ajh.26939] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2023] [Revised: 04/11/2023] [Accepted: 04/17/2023] [Indexed: 04/26/2023]
Affiliation(s)
- Slimane Allali
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université Paris Cité, Imagine Institute, Inserm U1163, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Juliette Elie
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université Paris Cité, Imagine Institute, Inserm U1163, Paris, France
| | - Lara Mayrand
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université Paris Cité, Imagine Institute, Inserm U1163, Paris, France
| | - Mariane de Montalembert
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Melissa Taylor
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Joséphine Brice
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Amandine Maire
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
| | - Rachel Rignault-Bricard
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université Paris Cité, Imagine Institute, Inserm U1163, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Claire Heilbronner
- Department of Pediatric Intensive care, Necker-Enfants malades Hospital, AP-HP, Université Paris Cité, Paris, France
| | - Jérémie F Cohen
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
- Centre of Research in Epidemiology and Statistics-CRESS, INSERM, Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Université Paris Cité, Paris, France
| | - Thiago T Maciel
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université Paris Cité, Imagine Institute, Inserm U1163, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
| | - Olivier Hermine
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université Paris Cité, Imagine Institute, Inserm U1163, Paris, France
- Laboratory of Excellence GR-Ex, Paris, France
- Department of Hematology, Necker-Enfants malades Hospital, AP-HP, Université Paris Cité, Paris, France
| |
Collapse
|
14
|
Louisson Z, Hermans SM, Buckley HL, Case BS, Taylor M, Curran-Cournane F, Lear G. Land use modification causes slow, but predictable, change in soil microbial community composition and functional potential. Environ Microbiome 2023; 18:30. [PMID: 37024971 PMCID: PMC10080853 DOI: 10.1186/s40793-023-00485-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Accepted: 03/19/2023] [Indexed: 06/19/2023]
Abstract
BACKGROUND Bacterial communities are critical to ecosystem functioning and sensitive to their surrounding physiochemical environment. However, the impact of land use change on microbial communities remains understudied. We used 16S rRNA gene amplicon sequencing and shotgun metagenomics to assess soil microbial communities' taxonomic and functional responses to land use change. We compared data from long-term grassland, exotic forest and horticulture reference sites to data from sites that transitioned from (i) Grassland to exotic forest or horticulture and from (ii) Exotic forest to grassland. RESULTS Community taxonomic and functional profiles of the transitional sites significantly differed from those within reference sites representing both their historic and current land uses (P < 0.001). The bacterial communities in sites that transitioned more recently were compositionally more similar to those representing their historic land uses. In contrast, the composition of communities from sites exposed to older conversion events had shifted towards the compositions at reference sites representing their current land use. CONCLUSIONS Our study indicates that microbial communities respond in a somewhat predictable way after a land use conversion event by shifting from communities reflecting their former land use towards those reflecting their current land use. Our findings help us to better understand the legacy effects of land use change on soil microbial communities and implications for their role in soil health and ecosystem functioning. Understanding the responsiveness of microbial communities to environmental disturbances will aid us in incorporating biotic variables into soil health monitoring techniques in the future.
Collapse
Affiliation(s)
- Z. Louisson
- School of Biological Sciences, University of Auckland, 3a Symonds Street, Auckland, 1010 New Zealand
| | - S. M. Hermans
- School of Science, Auckland University of Technology, 34 St Paul Street, Auckland, 1010 New Zealand
| | - H. L. Buckley
- School of Science, Auckland University of Technology, 34 St Paul Street, Auckland, 1010 New Zealand
| | - B. S. Case
- School of Science, Auckland University of Technology, 34 St Paul Street, Auckland, 1010 New Zealand
| | - M. Taylor
- Waikato Regional Council, 160 Ward St, Hamilton, 3204 New Zealand
| | - F. Curran-Cournane
- Joint Evidence Data and Insights, Ministry for the Environment, 45 Queens Street, Auckland, 1010 New Zealand
| | - G. Lear
- School of Biological Sciences, University of Auckland, 3a Symonds Street, Auckland, 1010 New Zealand
| |
Collapse
|
15
|
Gianoukakis A, Arnold S, Kahn S, Taylor M, Garralda E, Krebs M, Arkenau HT, Clark L, Fisher G, Subbiah V. 82TiP A modular, open-label, phase I/II study to evaluate the safety, tolerability, pharmacokinetics and efficacy of EP0031, a next generation selective RET inhibitor, in patients with advanced RET-altered malignancies. J Thorac Oncol 2023. [DOI: 10.1016/s1556-0864(23)00336-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2023]
|
16
|
Deutsch L, Cloutier A, Leahy G, Teubner A, Abraham A, Taylor M, Paine P, Lal S. Factors Associated With Strong Opioid Use For Non-Cancer Pain In Patients With Chronic Intestinal Failure. Clin Nutr ESPEN 2023. [DOI: 10.1016/j.clnesp.2022.09.289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/28/2023]
|
17
|
Tulleners T, Campbell C, Taylor M. The experience of nurses participating in peer group supervision: a qualitative systematic review. Nurse Educ Pract 2023; 69:103606. [PMID: 36989698 DOI: 10.1016/j.nepr.2023.103606] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2022] [Revised: 12/16/2022] [Accepted: 03/08/2023] [Indexed: 03/19/2023]
Abstract
AIM This systematic review will identify, appraise, and synthesise the best available qualitative studies exploring nurses' experiences of peer group supervision. The review purpose draws from the synthesised evidence recommendations to enhance policy and implementation of peer group supervision in practice. BACKGROUND Clinical Supervision is increasing in acceptance as a means of professional and best practice support in nursing. Peer group supervision is a non-hierarchical, leaderless model of clinical supervision delivery and is an option for implementation by nursing management when prioritising staff support with limited resources. This systematic review will provide a synthesis of the qualitative literature regarding the nursing peer group supervision experience. Understanding the experience of peer group supervision from those participating may provide constructive insights regarding implementation of this practice to benefit both nurse and patient driven outcomes. DESIGN Included are peer reviewed journals focused on nurses' experiences of participating in peer group supervision. Participants are registered nurses of any designation. Qualitative articles, written in English and relating to any area of nursing practice and/or speciality are included. The standards of the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Statement were used to guide the review. Two investigators independently screened titles, abstracts and selected full text studies describing the experience of peer group supervision. Pre-designed data extraction tools were utilised, and the review followed the Joanna Briggs Institute qualitative meta-aggregation approach with a hermeneutic interpretive analysis. RESULTS Results identified seven studies that met the inclusion criteria. A total of 52 findings that described the experiences of nursing peer group supervision are synthesised into eight categories. Four overarching synthesised findings resulted: 1. facilitating professional growth 2. trusting the group 3. professional learning experience and 4. shared experiences. Benefits such as sharing of experiences whilst receiving feedback and support were identified. Challenges identified related to group processes. CONCLUSIONS The paucity of international research into nursing peer group supervision poses challenges for nurse decision makers. Significantly, this review provides insight into the value of peer group supervision for nurses regardless of clinical context and setting. The ability to share and reflect with nursing peers enhances both personal and professional aspects of practice. The worth of the peer group supervision model varied across studies however the outcomes provided important insights into facilitating professional growth, enabling a space to share experiences and reflect, and to build teams where trust and respect develops in groups.
Collapse
|
18
|
Reddy A, Taylor M, Batson B, Islam E. Pleural invasion in non-small cell lung cancer: a case report. Am J Med Sci 2023. [DOI: 10.1016/s0002-9629(23)00254-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|
19
|
Darbyshire AR, Towers A, Harrison R, Taylor M, Carter NC, Toh SKC, Mercer SJ. Routine ultrasound for suspected appendicitis in children: a single-centre retrospective cohort study. Ann R Coll Surg Engl 2023; 105:72-76. [PMID: 35442809 PMCID: PMC9773294 DOI: 10.1308/rcsann.2021.0326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/08/2022] [Indexed: 12/24/2022] Open
Abstract
INTRODUCTION Appendicitis continues to be a common surgical emergency in children, but its diagnosis remains challenging. Use of diagnostic imaging to confirm appendicitis has gained popularity in some countries because it is associated with lower negative appendicectomy rates. This study reports our centre's experience of adopting routine ultrasound for the investigation of suspected appendicitis in children. METHODS A single-centre retrospective cohort study was performed investigating all children aged 5-16 years admitted under surgeons with suspected appendicitis, in January-December 2019. Primary outcomes were the rate of ultrasound use, its accuracy in diagnosing/excluding appendicitis and negative appendicectomy rate. Other outcomes were treatment received, length of stay and complications. RESULTS The majority of the 193 children with suspected appendicitis underwent a diagnostic ultrasound (87.5%). Ultrasound was highly sensitive (0.90, 95% confidence interval (CI) 0.81-0.96) and specific (1.0, 95% CI 0.96-1.0) for appendicitis in this study. Negative appendicectomy rate was extremely low (1.4%). Laparoscopic appendicectomy was the preferred management (75/86), with one case started open and no conversions to open. A minority of cases of simple appendicitis (10/86) were treated primarily with antibiotics. Rates of complex appendicitis and postoperative complications were similar to other studies. CONCLUSION Ultrasound can be highly sensitive and specific for appendicitis. Its routine use to confirm appendicitis prior to surgery is associated with a low negative appendicectomy rate. This is a major change in practice for a general surgical unit in the United Kingdom.
Collapse
Affiliation(s)
| | - A Towers
- Portsmouth Hospitals University NHS Trust, UK
| | - R Harrison
- Portsmouth Hospitals University NHS Trust, UK
| | - M Taylor
- Portsmouth Hospitals University NHS Trust, UK
| | - NC Carter
- Portsmouth Hospitals University NHS Trust, UK
| | - SKC Toh
- Portsmouth Hospitals University NHS Trust, UK
| | - SJ Mercer
- Portsmouth Hospitals University NHS Trust, UK
| |
Collapse
|
20
|
Shrestha S, Stapp J, Taylor M, Leach R, Carreiro S, Indic P. Towards Device Agnostic Detection of Stress and Craving in Patients with Substance Use Disorder. Proc Annu Hawaii Int Conf Syst Sci 2023; 2023:3156-3163. [PMID: 36788990 PMCID: PMC9925294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
Novel technologies have great potential to improve the treatment of individuals with substance use disorder (SUD) and to reduce the current high rate of relapse (i.e. return to drug use). Wearable sensor-based systems that continuously measure physiology can provide information about behavior and opportunities for real-time interventions. We have previously developed an mHealth system which includes a wearable sensor, a mobile phone app, and a cloud-based server with embedded machine learning algorithms which detect stress and craving. The system functions as a just-in-time intervention tool to help patients de-escalate and as a tool for clinicians to tailor treatment based on stress and craving patterns observed. However, in our pilot work we found that to deploy the system to diverse socioeconomic populations and to increase usability, the system must be able to work efficiently with cost-effective and popular commercial wearable devices. To make the system device agnostic, methods to transform the data from a commercially available wearable for use in algorithms developed from research grade wearable sensor are proposed. The accuracy of these transformations in detecting stress and craving in individuals with SUD is further explored.
Collapse
|
21
|
Haydon HM, Lotfaliany M, Jones C, Chelberg G, Horstmanshof L, Taylor M, Carey M, Snoswell CL, Hicks R, Banbury A. Health literacy, dementia knowledge and perceived utility of digital health modalities among future health professionals. Australas J Ageing 2022. [DOI: 10.1111/ajag.13149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2021] [Revised: 09/02/2022] [Accepted: 09/20/2022] [Indexed: 11/07/2022]
Affiliation(s)
- Helen M. Haydon
- Centre for Online Health The University of Queensland Woolloongabba Queensland Australia
- Centre for Health Services Research The University of Queensland Woolloongabba Queensland Australia
| | - Mojtaba Lotfaliany
- Centre for Online Health The University of Queensland Woolloongabba Queensland Australia
- Centre for Health Services Research The University of Queensland Woolloongabba Queensland Australia
- The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health Deakin University Geelong Victoria Australia
| | - Cindy Jones
- Faculty of Health Sciences and Medicine Bond University Robina Queensland Australia
- Menzies Health Institute Queensland Southport Queensland Australia
| | - Georgina R. Chelberg
- Centre for Online Health The University of Queensland Woolloongabba Queensland Australia
- Centre for Health Services Research The University of Queensland Woolloongabba Queensland Australia
| | - Louise Horstmanshof
- Faculty of Health Southern Cross University Lismore New South Wales Australia
| | - Melissa Taylor
- School of Nursing and Midwifery, Centre for Health Research The University of Southern Queensland Ipswich Queensland Australia
| | - Melissa Carey
- Centre for Health Research The University of Southern Queensland Ipswich Queensland Australia
- University of Auckland Auckland New Zealand
| | - Centaine L. Snoswell
- Centre for Online Health The University of Queensland Woolloongabba Queensland Australia
- Centre for Health Services Research The University of Queensland Woolloongabba Queensland Australia
| | - Richard Hicks
- School of Psychology, Faculty of Society and Design Bond University Robina Queensland Australia
| | - Annie Banbury
- Centre for Online Health The University of Queensland Woolloongabba Queensland Australia
- Centre for Health Services Research The University of Queensland Woolloongabba Queensland Australia
| |
Collapse
|
22
|
Paldino A, Dal Ferro M, Stolfo D, Gandin I, Graw S, Gigli M, Medo K, Gagno G, Zaffalon D, Castrichini M, Mase' M, Merlo M, Taylor M, Mestroni L, Sinagra G. Prognostic prediction of genotype versus phenotype in genetic cardiomyopathies. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
In cardiomyopathies (CMPs), the diverse genetic background often leads to phenotypic heterogeneity. Currently, genotype-phenotype studies are founded on clinical phenotype-based classification of CMPs, contributing possible biases due to the exclusion of specific and unascertained phenotypic expressions of CMP genes.
Purpose
We sought to define differences in outcome when stratifying patients based on phenotype at presentation compared with genotype in a large cohort of CMP patients with positive genetic testing.
Methods
In this study, we included the whole spectrum of non-hypertrophic CMP phenotypes, genetically determined: dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), left ventricular arrhythmogenic cardiomyopathy (ALVC) and biventricular ARVC (BiV). The primary and secondary outcomes were: 1) all-cause mortality/heart transplant (D/HT); 2) heart failure-related death/heart transplant/left ventricular assist device implantation (DHF/HT/VAD); and 3) sudden cardiac death/life-threatening ventricular arrhythmias (SCD/MVA).
Results
Two hundred and eighty-one patients (80% DCM) carrying pathogenic or likely pathogenic variants were included in this study. The phenotype was classified as DCM, ARVC, ALVC and BiV according to current consensus criteria. The median follow-up was 188 months. Variants in titin (TTN; 34%) and sarcomeric genes (SARC; 22%) were the most frequent genotypes and almost invariably associated with a DCM phenotype. DSP, LMNA and FLNC displayed more heterogeneous phenotypic presentations, including DCM, ARVC, ALVC, BiV. At survival analysis, the arrhythmic outcome occurred more frequently in patients without a DCM phenotype and in carriers of DSP, PKP2, LMNA and FLNC variants. However, after adjustment for age and sex, the genotype-based classification but not the phenotype-based classification was predictive of the arrhythmic outcome. LMNA showed the worst trend in term of D/HT and DHF/HT/LVAD.
Conclusions
In genetic cardiomyopathies, genotype is associated with significant phenotypic heterogeneity. Nevertheless, in our study, the genotypic-based classification showed higher precision in predicting CMP patients' outcome in respect to the phenotype-based classification. These findings add to the current understanding of inherited CMPs and may implement the risk stratification of patients with positive genetic testing.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- A Paldino
- University Hospital Riuniti, Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy , Trieste , Italy
| | - M Dal Ferro
- University Hospital Riuniti, Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy , Trieste , Italy
| | - D Stolfo
- University Hospital Riuniti, Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy , Trieste , Italy
| | - I Gandin
- University of Trieste, Biostatistics Unit , Trieste , Italy
| | - S Graw
- University of Colorado, Cardiovascular Institute and Adult Medical Genetics Program , Denver , United States of America
| | - M Gigli
- University Hospital Riuniti, Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy , Trieste , Italy
| | - K Medo
- University of Colorado, Cardiovascular Institute and Adult Medical Genetics Program , Denver , United States of America
| | - G Gagno
- University Hospital Riuniti, Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy , Trieste , Italy
| | - D Zaffalon
- University Hospital Riuniti, Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy , Trieste , Italy
| | - M Castrichini
- University Hospital Riuniti, Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy , Trieste , Italy
| | - M Mase'
- University Hospital Riuniti, Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy , Trieste , Italy
| | - M Merlo
- University Hospital Riuniti, Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy , Trieste , Italy
| | - M Taylor
- University of Colorado, Cardiovascular Institute and Adult Medical Genetics Program , Denver , United States of America
| | - L Mestroni
- University of Colorado, Cardiovascular Institute and Adult Medical Genetics Program , Denver , United States of America
| | - G Sinagra
- University Hospital Riuniti, Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy , Trieste , Italy
| |
Collapse
|
23
|
Pena B, Knight W, Cavasin M, Ferrari I, Abdel-Hafiz M, Vagnozzi R, Bosi S, Park D, Shandas R, Song K, McKinsey T, Sbaizero O, Taylor M, Prato M, Mestroni L. Injectable carbon nanotube-functionalized hydrogel as a tool for cardiac tissue engineering. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.3016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background/Introduction
Heart failure (HF) is an expensive major public health problem in the United States and around the world (1). The current treatments for HF are aimed at reducing symptoms, slowing disease progression, and reducing mortality and not aimed at repairing heart muscle or restoring function. Furthermore, even with these treatments, approximately half of patients with HF will die within 5 years of diagnosis (2). Cardiac transplantation remains the only definitive treatment for those affected with end-stage HF, but availability of donor hearts remains a major limitation (3).
Purpose
The ability of the adult heart to regenerate cardiomyocytes (CMs) lost after injury is limited, generating interest in developing tissue engineering therapies to avoid progression towards HF. Rigid carbon nanotubes (CNTs) scaffolds have been used to improve CMs viability, proliferation, and maturation (4), but require undesirable invasive surgeries for implantation. To overcome this limitation, we engineered an injectable reverse thermal gel (RTG) functionalized with CNTs (RTG-CNT) that transitions from a liquid-solution to a gel-based matrix shortly after reaching body temperature allowing for a liquid-based delivery rapidly followed by a stable-gel localization (5).
Methods and results
Here we show experimental evidences the RTG-CNT hydrogel, used as a three-dimensional (3D) niche to culture human induced pluripotent stem cells (hiPSC)-CMs, promotes hiPSC-CMs alignment and elongation with increased Cx43 localization and improved contraction function when compared with traditional two-dimensional (2D) fibronectin controls and plain 3D RTG system without CNTs. Moreover, the short-term (4-week) biocompatibility of the RTG-CNT hydrogel was also assessed in a mouse model (intracardial injection). The results confirmed that the RTG-CNT hydrogel is well tolerated by the cardiac tissue.
Conclusion
Our results indicated that the injectable RTG-CNT hydrogel has the potential to be used as a minimally invasive tool for cardiac tissue engineering efforts.
Funding Acknowledgement
Type of funding sources: Other. Main funding source(s): NATIONAL HEART, LUNG, AND BLOOD (NHLBI) INSTITUTE
Collapse
Affiliation(s)
- B Pena
- University of Colorado , Aurora , United States of America
| | - W Knight
- University of Colorado , Aurora , United States of America
| | - M Cavasin
- University of Colorado , Aurora , United States of America
| | - I Ferrari
- University of Colorado , Aurora , United States of America
| | - M Abdel-Hafiz
- University of Colorado , Aurora , United States of America
| | - R Vagnozzi
- University of Colorado , Aurora , United States of America
| | - S Bosi
- University of Trieste, Chemical and Pharmaceutical Sciences , Trieste , Italy
| | - D Park
- University of Colorado , Aurora , United States of America
| | - R Shandas
- University of Colorado , Aurora , United States of America
| | - K Song
- University of Colorado , Aurora , United States of America
| | - T McKinsey
- University of Colorado , Aurora , United States of America
| | - O Sbaizero
- University of Trieste, Engineering and Architecture , Trieste , Italy
| | - M Taylor
- University of Colorado , Aurora , United States of America
| | - M Prato
- University of Trieste, Chemical and Pharmaceutical Sciences , Trieste , Italy
| | - L Mestroni
- University of Colorado , Aurora , United States of America
| |
Collapse
|
24
|
Best O, Cox L, Ward A, Graham C, Bayliss L, Black B, Burton L, Carey M, Davis T, Derrington K, Elliott J, Jayasinghe T, Luyke T, Maher D, McGregor R, Ng L, O'Malley L, Roderick G, Sheridan G, Stanbury L, Taylor M, Terry V, Tulleners T, Walker J. Educating the educators: Implementing cultural safety in the nursing and midwifery curriculum. Nurse Educ Today 2022; 117:105473. [PMID: 35917706 DOI: 10.1016/j.nedt.2022.105473] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/04/2022] [Revised: 06/13/2022] [Accepted: 07/06/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND The Australian Nursing and Midwifery Accreditation Council mandates the teaching of cultural safety in Bachelor of Nursing and Midwifery programs in Australia. However nursing and midwifery academics may lack the awareness and knowledge required to share and develop cultural safety practices with their students. Specific cultural safety professional development for academics may be needed. OBJECTIVES This research explores how nursing and midwifery academics at an Australian university understand cultural safety and whether they are equipped to embed it in the curriculum. It also examines whether professional development workshops can support academics to prepare for cultural safety. METHODS An intervention involving three cultural safety professional development workshops was offered to nursing academics at an Australian university. The authors used qualitative surveys to consider whether the workshops deepened participants' understanding of cultural safety and developed the self-reflection required to embed cultural safety in teaching. RESULTS The workshops contributed to participants' improved understandings of culture, colonisation, white privilege and the need for self-reflection, but not all participants developed a working knowledge of cultural safety practice. CONCLUSION Professional development workshops can assist nursing and midwifery academics to develop their knowledge of cultural safety, but detailed, contextual understanding is likely to need more than three sessions. Academics' motivations to include cultural safety in their teaching may be linked to their desire for patient-driven and equitable services and a desire to meet accreditation requirements.
Collapse
Affiliation(s)
- Odette Best
- School of Nursing and Midwifery, University of Southern Queensland, Australia.
| | - Leonie Cox
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Aletha Ward
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Coralie Graham
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Luke Bayliss
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Barbara Black
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Lucinda Burton
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Melissa Carey
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Teresa Davis
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Kate Derrington
- Library Services, University of Southern Queensland, Australia
| | - Jessie Elliott
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Thenuja Jayasinghe
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Trish Luyke
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Dianne Maher
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Rowena McGregor
- Library Services, University of Southern Queensland, Australia
| | - Linda Ng
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Lee O'Malley
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Geraldine Roderick
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Georgina Sheridan
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Linda Stanbury
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Melissa Taylor
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Victoria Terry
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Tracey Tulleners
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| | - Jan Walker
- School of Nursing and Midwifery, University of Southern Queensland, Australia
| |
Collapse
|
25
|
Hu M, Subbiah V, Mansfield A, Taylor M, Schuler M, Zhu V, Hadoux J, Curigliano G, Wirth L, Garralda E, Adkins D, Godbert Y, Ahn MJ, Cassier P, Cho B, Lin CC, Barata T, Zalutskaya A, Scalori A, Brose M. 1654P Updated ARROW data: Pralsetinib in patients (pts) with advanced or metastatic RET-altered thyroid cancer (TC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1734] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
26
|
Garrido Lopez P, Siena S, Taylor M, Beringer A, Bordogna W, Fajardo O, Nikolaidis C. 110P Characteristics and survival outcomes of patients (pts) with RET fusion-positive (RET-fp) solid tumours receiving non-RET inhibitor (RETi) therapy in a real-world setting. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
27
|
Sterlin A, de Montalembert M, Taylor M, Mensah S, Vandaele M, Lanzeray A, Poiraud L, Allali S. Impact of COVID-19 pandemic on access to online therapeutic education programs for children with sickle cell disease. J Pediatr Nurs 2022; 66:179-183. [PMID: 35816905 PMCID: PMC9265241 DOI: 10.1016/j.pedn.2022.06.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/08/2022] [Revised: 06/23/2022] [Accepted: 06/28/2022] [Indexed: 11/05/2022]
Abstract
BACKGROUND Sickle cell disease (SCD) is a lifelong disease for which outcomes may be influenced by patients' self-care knowledge. Therapeutic education (TPE) is a patient-centered teaching instrument based on patient's adaptative processes and needs. TPE was developed in the Paris area by a pediatric health network using interactive face-to-face meetings. The COVID-19 pandemic has impacted the TPE modalities by promoting online training. Our aims were to evaluate the accessibility of patients with SCD to online TPE. METHODS We compared sessions of TPE before and after the onset of the pandemic: the number of sessions, performed face-to-face or online, individual or in a group. We also recorded the number of participants in each session and their age, school level, and department in France. FINDINGS We observed an increase in the total number of trained children, but participation varied greatly according to the geographical area of residence, with a decrease from 22.4% to 4.9% in the proportion of attendees living in the most socio-economically deprived French departments. DISCUSSION Online TPE is feasible for patients with SCD but with unequal access according to socio-economic status. APPLICATION TO PRACTICE Access to TPE needs to be improved for patients living in socially disadvantaged areas.
Collapse
Affiliation(s)
- Alizee Sterlin
- Réseau Francilien de Soins des Enfants Drépanocytaires, Hôpital Necker-Enfants malades, et Agence Régionale de Santé Ile-de-France, Paris, France
| | - Mariane de Montalembert
- Réseau Francilien de Soins des Enfants Drépanocytaires, Hôpital Necker-Enfants malades, et Agence Régionale de Santé Ile-de-France, Paris, France.; Department of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Hôpital Necker-Enfants malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
| | - Melissa Taylor
- Department of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Hôpital Necker-Enfants malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France
| | - Sandrine Mensah
- Réseau Francilien de Soins des Enfants Drépanocytaires, Hôpital Necker-Enfants malades, et Agence Régionale de Santé Ile-de-France, Paris, France
| | - Marie Vandaele
- Réseau Francilien de Soins des Enfants Drépanocytaires, Hôpital Necker-Enfants malades, et Agence Régionale de Santé Ile-de-France, Paris, France
| | - Agathe Lanzeray
- Réseau Francilien de Soins des Enfants Drépanocytaires, Hôpital Necker-Enfants malades, et Agence Régionale de Santé Ile-de-France, Paris, France.; Unité Transversale d'Education Thérapeutique, Hôpital Necker Enfants Malades, Paris, France
| | - Louise Poiraud
- Réseau Francilien de Soins des Enfants Drépanocytaires, Hôpital Necker-Enfants malades, et Agence Régionale de Santé Ile-de-France, Paris, France
| | - Slimane Allali
- Réseau Francilien de Soins des Enfants Drépanocytaires, Hôpital Necker-Enfants malades, et Agence Régionale de Santé Ile-de-France, Paris, France.; Department of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Hôpital Necker-Enfants malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France
| |
Collapse
|
28
|
Lee K, Sutaria N, Marani M, Choi J, Roh Y, Parthasarathy V, Deng J, Bordeaux Z, Taylor M, Pritchard T, Alajmi A, Adawi W, Semenov Y, Alphonse M, Kwatra S. 857 Racial differences in dysregulation of the renin-angiotensin-aldosterone system in patients with prurigo nodularis. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
29
|
Taylor M, Cook C, Liu Y, Schmidt R, Hailer A, North J, Wang H, Kashem S, Purdom E, Marson A, Ramos S, Cho R, Cheng J. 509 A single-cell transcriptional gradient in human cutaneous memory T cells suppresses pathogenic Th17 inflammation. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
30
|
Taylor M, Parthasarathy V, Deng J, Bordeaux Z, Lee K, Alphonse M, Kwatra S. 697 Racial differences in inflammatory biomarkers in hidradenitis suppurativa patients. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
31
|
Le T, Brown I, Taylor M, Deng J, Parthasarathy V, Bordeaux Z, Alphonse M, Alhariri J, Kang S, Semenov Y, Kwatra S. 195 Cutaneous toxicities associated with immune checkpoint inhibitors: An observational, pharmacovigilance study. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
32
|
Hailer A, Liu Y, Wang H, Taylor M, Cook C, North J, Mauro T, Purdom E, Cheng J, Cho R. 862 RashX: Immune single-cell transcriptional classification of human chronic inflammatory skin disease. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Vasavda C, Wan G, Lu C, Sutaria N, Nguyen N, Szeto M, Adawi W, Deng J, Parthasarathy V, Bordeaux Z, Taylor M, Marani M, Lee K, Alphonse M, Kang S, Semenov Y, Gusev A, Kwatra S. 679 A polygenic risk score uncovers racial and genetic differences in susceptibility to prurigo nodularis in patients of African ancestry. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
34
|
Dinnes J, Sharma P, Berhane S, van Wyk SS, Nyaaba N, Domen J, Taylor M, Cunningham J, Davenport C, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Van den Bruel A, Deeks JJ. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev 2022; 7:CD013705. [PMID: 35866452 PMCID: PMC9305720 DOI: 10.1002/14651858.cd013705.pub3] [Citation(s) in RCA: 55] [Impact Index Per Article: 27.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
BACKGROUND Accurate rapid diagnostic tests for SARS-CoV-2 infection would be a useful tool to help manage the COVID-19 pandemic. Testing strategies that use rapid antigen tests to detect current infection have the potential to increase access to testing, speed detection of infection, and inform clinical and public health management decisions to reduce transmission. This is the second update of this review, which was first published in 2020. OBJECTIVES To assess the diagnostic accuracy of rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. We consider accuracy separately in symptomatic and asymptomatic population groups. Sources of heterogeneity investigated included setting and indication for testing, assay format, sample site, viral load, age, timing of test, and study design. SEARCH METHODS We searched the COVID-19 Open Access Project living evidence database from the University of Bern (which includes daily updates from PubMed and Embase and preprints from medRxiv and bioRxiv) on 08 March 2021. We included independent evaluations from national reference laboratories, FIND and the Diagnostics Global Health website. We did not apply language restrictions. SELECTION CRITERIA We included studies of people with either suspected SARS-CoV-2 infection, known SARS-CoV-2 infection or known absence of infection, or those who were being screened for infection. We included test accuracy studies of any design that evaluated commercially produced, rapid antigen tests. We included evaluations of single applications of a test (one test result reported per person) and evaluations of serial testing (repeated antigen testing over time). Reference standards for presence or absence of infection were any laboratory-based molecular test (primarily reverse transcription polymerase chain reaction (RT-PCR)) or pre-pandemic respiratory sample. DATA COLLECTION AND ANALYSIS We used standard screening procedures with three people. Two people independently carried out quality assessment (using the QUADAS-2 tool) and extracted study results. Other study characteristics were extracted by one review author and checked by a second. We present sensitivity and specificity with 95% confidence intervals (CIs) for each test, and pooled data using the bivariate model. We investigated heterogeneity by including indicator variables in the random-effects logistic regression models. We tabulated results by test manufacturer and compliance with manufacturer instructions for use and according to symptom status. MAIN RESULTS We included 155 study cohorts (described in 166 study reports, with 24 as preprints). The main results relate to 152 evaluations of single test applications including 100,462 unique samples (16,822 with confirmed SARS-CoV-2). Studies were mainly conducted in Europe (101/152, 66%), and evaluated 49 different commercial antigen assays. Only 23 studies compared two or more brands of test. Risk of bias was high because of participant selection (40, 26%); interpretation of the index test (6, 4%); weaknesses in the reference standard for absence of infection (119, 78%); and participant flow and timing 41 (27%). Characteristics of participants (45, 30%) and index test delivery (47, 31%) differed from the way in which and in whom the test was intended to be used. Nearly all studies (91%) used a single RT-PCR result to define presence or absence of infection. The 152 studies of single test applications reported 228 evaluations of antigen tests. Estimates of sensitivity varied considerably between studies, with consistently high specificities. Average sensitivity was higher in symptomatic (73.0%, 95% CI 69.3% to 76.4%; 109 evaluations; 50,574 samples, 11,662 cases) compared to asymptomatic participants (54.7%, 95% CI 47.7% to 61.6%; 50 evaluations; 40,956 samples, 2641 cases). Average sensitivity was higher in the first week after symptom onset (80.9%, 95% CI 76.9% to 84.4%; 30 evaluations, 2408 cases) than in the second week of symptoms (53.8%, 95% CI 48.0% to 59.6%; 40 evaluations, 1119 cases). For those who were asymptomatic at the time of testing, sensitivity was higher when an epidemiological exposure to SARS-CoV-2 was suspected (64.3%, 95% CI 54.6% to 73.0%; 16 evaluations; 7677 samples, 703 cases) compared to where COVID-19 testing was reported to be widely available to anyone on presentation for testing (49.6%, 95% CI 42.1% to 57.1%; 26 evaluations; 31,904 samples, 1758 cases). Average specificity was similarly high for symptomatic (99.1%) or asymptomatic (99.7%) participants. We observed a steady decline in summary sensitivities as measures of sample viral load decreased. Sensitivity varied between brands. When tests were used according to manufacturer instructions, average sensitivities by brand ranged from 34.3% to 91.3% in symptomatic participants (20 assays with eligible data) and from 28.6% to 77.8% for asymptomatic participants (12 assays). For symptomatic participants, summary sensitivities for seven assays were 80% or more (meeting acceptable criteria set by the World Health Organization (WHO)). The WHO acceptable performance criterion of 97% specificity was met by 17 of 20 assays when tests were used according to manufacturer instructions, 12 of which demonstrated specificities above 99%. For asymptomatic participants the sensitivities of only two assays approached but did not meet WHO acceptable performance standards in one study each; specificities for asymptomatic participants were in a similar range to those observed for symptomatic people. At 5% prevalence using summary data in symptomatic people during the first week after symptom onset, the positive predictive value (PPV) of 89% means that 1 in 10 positive results will be a false positive, and around 1 in 5 cases will be missed. At 0.5% prevalence using summary data for asymptomatic people, where testing was widely available and where epidemiological exposure to COVID-19 was suspected, resulting PPVs would be 38% to 52%, meaning that between 2 in 5 and 1 in 2 positive results will be false positives, and between 1 in 2 and 1 in 3 cases will be missed. AUTHORS' CONCLUSIONS Antigen tests vary in sensitivity. In people with signs and symptoms of COVID-19, sensitivities are highest in the first week of illness when viral loads are higher. Assays that meet appropriate performance standards, such as those set by WHO, could replace laboratory-based RT-PCR when immediate decisions about patient care must be made, or where RT-PCR cannot be delivered in a timely manner. However, they are more suitable for use as triage to RT-PCR testing. The variable sensitivity of antigen tests means that people who test negative may still be infected. Many commercially available rapid antigen tests have not been evaluated in independent validation studies. Evidence for testing in asymptomatic cohorts has increased, however sensitivity is lower and there is a paucity of evidence for testing in different settings. Questions remain about the use of antigen test-based repeat testing strategies. Further research is needed to evaluate the effectiveness of screening programmes at reducing transmission of infection, whether mass screening or targeted approaches including schools, healthcare setting and traveller screening.
Collapse
Affiliation(s)
- Jacqueline Dinnes
- Test Evaluation Research Group, Institute of Applied Health Research, University of Birmingham, Birmingham, UK
- NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK
| | - Pawana Sharma
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - Sarah Berhane
- NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK
| | - Susanna S van Wyk
- Centre for Evidence-based Health Care, Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
| | - Nicholas Nyaaba
- Infectious Disease Unit, 37 Military Hospital, Cantonments, Ghana
| | - Julie Domen
- Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
| | - Melissa Taylor
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Jane Cunningham
- Global Malaria Programme, World Health Organization, Geneva, Switzerland
| | - Clare Davenport
- Test Evaluation Research Group, Institute of Applied Health Research, University of Birmingham, Birmingham, UK
- NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK
| | | | | | - Lotty Hooft
- Cochrane Netherlands, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
| | - Mariska Mg Leeflang
- Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
| | | | - René Spijker
- Cochrane Netherlands, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- Medical Library, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health, Amsterdam, Netherlands
| | - Jan Y Verbakel
- Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
| | - Yemisi Takwoingi
- Test Evaluation Research Group, Institute of Applied Health Research, University of Birmingham, Birmingham, UK
- NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK
| | - Sian Taylor-Phillips
- Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK
| | - Ann Van den Bruel
- Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
| | - Jonathan J Deeks
- Test Evaluation Research Group, Institute of Applied Health Research, University of Birmingham, Birmingham, UK
- NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK
| |
Collapse
|
35
|
Christianson K, Owusu V, Taylor M, Hopfe D, Pavilionis P, Murray NG. A-09 Challenges in Measuring Repetitive Head Impacts, Cognition, and Eye Movements in High School Football Players. Arch Clin Neuropsychol 2022. [DOI: 10.1093/arclin/acac32.09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Purpose: Assess the feasibility of measuring Repetitive Head Impacts (RHI), cognition, and eye movements across a single season of high school football. Methods: Twelve players were provided an instrumented mouthguard (3200 Hz; Prevent Biometrics, Edina, MA) to evaluate RHI. Mouthguard use was assessed by total impacts and number of games/practices. Seven players also agreed to complete cognitive (ImPACT) and custom eye-tracking (500 Hz; EyeLink II) assessments pre-, mid-, and post-season. Multiple repeated measure ANOVA’s were completed using standard composite scores for ImPACT and oculomotor metrics. Results: Fifty percent of players ever used their mouthguard, and substantial variability in total impacts (M = 86.5, SD = 98.0, Range = 7–277) and number of games/practices (M = 9.8, SD = 7.6, Range = 2–23) were observed among players who did use their mouthguard. Specific completion rates for the 3 cognitive and 3 eye-tracking assessments were 71% each, and 57% of players completed all 6 scheduled assessments. Repeated measures ANOVA indicated Visual Motor Speed (VMS) improved between assessments (p = 0.015). Post hoc analysis showed both VMS and Verbal Memory increased from pre- to mid-season (−5.30(95%CI, −10.47 to −0.12), p = 0.046), (−0.20(95%CI, −13.00 to −1.41), p = 0.024). Conclusions: Variability in mouthguard use and missing assessment rates represent practical challenges in prospectively measuring RHI and utilizing multiple longitudinal assessment methods in high school football players. Although ImPACT results should be interpreted cautiously, future research should consider the potential role of practice effects and/or intentionally poor pre-season effort to explain the increase in performance during the season. A larger sample size will increase the possibility of measuring the effect of RHI on assessment outcomes.
Collapse
|
36
|
Abstract
BACKGROUND The World Health Organization (WHO) recommends artemisinin-based combination therapies (ACTs) to treat uncomplicated Plasmodium falciparum malaria. Concerns about artemisinin resistance have led to global initiatives to develop new partner drugs to protect artemisinin derivatives in ACT. Pyronaridine-artesunate is a novel ACT. OBJECTIVES To evaluate the efficacy of pyronaridine-artesunate compared to alternative ACTs for treating people with uncomplicated P falciparum malaria, and to evaluate the safety of pyronaridine-artesunate and other pyronaridine treatments compared to alternative treatments. SEARCH METHODS We searched the Cochrane Infectious Diseases Group Specialized Register; Cochrane Central Register of Controlled Trials (CENTRAL), published in the Cochrane Library; MEDLINE; Embase; and LILACS. We also searched ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform, and the ISRCTN registry for ongoing or recently completed trials. The date of the last search was 27 October 2021. SELECTION CRITERIA For the efficacy analysis, we included randomized controlled trials (RCTs) of pyronaridine-artesunate for treating uncomplicated P falciparum malaria. For the safety analysis, we included RCTs that used pyronaridine alone or in combination with any other antimalarials. In addition to these analyses, we conducted a separate systematic review summarizing data on safety from non-randomized studies (NRS) of any patient receiving pyronaridine (NRS safety review). DATA COLLECTION AND ANALYSIS: Two review authors independently extracted all data and assessed the certainty of the evidence. We meta-analysed data to calculate risk ratios (RRs) for treatment failures between comparisons, and for safety outcomes between and across comparisons. MAIN RESULTS We included 10 relevant RCTs. Seven RCTs were co-funded by Shin Poong Pharmaceuticals, and three were funded by government agencies. Efficacy analysis (RCTs) For the efficacy analysis, we identified five RCTs comprising 5711 participants. This included 4465 participants from 13 sites in Africa, and 1246 participants from five sites in Asia. The analysis included 541 children aged less than five years. Overall, pyronaridine-artesunate had a polymerase chain reaction (PCR)-adjusted treatment failure rate of less than 5%. We evaluated pyronaridine-artesunate versus the following. • Artemether-lumefantrine. Pyronaridine artesunate may perform better for PCR-adjusted failures at day 28 (RR 0.59, 95% confidence interval (CI) 0.26 to 1.31; 4 RCTs, 3068 participants, low-certainty evidence); for unadjusted failures at day 28 (RR 0.27, 95% CI 0.13 to 0.58; 4 RCTs, 3149 participants, low-certainty evidence); and for unadjusted failures at day 42 (RR 0.61, 95% CI 0.46 to 0.82; 4 RCTs, 3080 participants, low-certainty evidence). For PCR-adjusted failures at day 42, there may be little or no difference between groups (RR 0.86, 95% CI 0.49 to 1.51; 4 RCTs, 2575 participants, low-certainty evidence). • Artesunate-amodiaquine. Pyronaridine artesunate may perform better for PCR-adjusted failures at day 28 (RR 0.55, 95% CI 0.11 to 2.77; 1 RCT, 1245 participants, low-certainty evidence); probably performs better for unadjusted failures at day 28 (RR 0.49, 95% CI 0.30 to 0.81; 1 RCT, 1257 participants, moderate-certainty evidence); may make little or no difference for PCR-adjusted failures at day 42 (RR 0.98, 95% CI 0.20 to 4.83; 1 RCT, 1091 participants, low-certainty evidence); and probably makes little or no difference for unadjusted failures at day 42 (RR 0.98, 95% CI 0.78 to 1.23; 1 RCT, 1235 participants, moderate-certainty evidence). • Mefloquine plus artesunate. Pyronaridine artesunate may perform better for PCR-adjusted failures at day 28 (RR 0.37, 95% CI 0.13 to 1.05; 1 RCT, 1117 participants, low-certainty evidence); probably performs better for unadjusted failures at day 28 (RR 0.36, 95% CI 0.17 to 0.78; 1 RCT, 1120 participants, moderate-certainty evidence); may make little or no difference for unadjusted failures at day 42 (RR 0.84, 95% CI 0.54 to 1.31; 1 RCT, 1059 participants, low-certainty evidence); but may lead to higher PCR-adjusted failures at day 42 (RR 1.80, 95% CI 0.90 to 3.57; 1 RCT, 1037 participants, low-certainty evidence). Safety analysis (RCTs) For the RCT safety analysis, we identified eight RCTs, one of which was delineated by study site, comparing pyronaridine-artesunate to other antimalarials. Pyronaridine-artesunate was associated with raised liver enzymes compared to other antimalarials: alanine aminotransferase (ALT) (RR 3.59, 95% CI 1.76 to 7.33; 8 RCTS, 6669 participants, high-certainty evidence) and aspartate transaminase (AST) (RR 2.22, 95% CI 1.12 to 4.41; 8 RCTs, 6669 participants, moderate-certainty evidence). No such effect was demonstrated with bilirubin (RR 1.03, 95% CI 0.49 to 2.18; 7 RCTs, 6384 participants, moderate-certainty evidence). There was one reported case in which raised ALT occurred with raised bilirubin. No study reported severe drug-induced liver injury. Electrocardiograph (ECG) abnormalities were less common with pyronaridine-artesunate compared to other antimalarials. We identified no other safety concerns. NRS safety review A review on safety in NRS allowed us to increase the population within which safety was assessed. We included seven studies with 9546 participants: five single-arm observational studies, one cohort event monitoring study, and one dose-escalation study. All studies provided data on adverse event frequency, with a small number of participants experiencing serious adverse events and adverse effects related to pyronaridine: serious adverse events average 0.37%; drug-related 9.0%. In two studies reporting elevations in liver enzymes, small percentages of participants (2.4% and 14.1% respectively) experienced increases in either ALT, AST, or bilirubin on day 7; however, these were small increases that returned to normal by day 42. AUTHORS' CONCLUSIONS: Pyronaridine-artesunate was efficacious against uncomplicated P falciparum malaria; achieved a PCR-adjusted treatment failure rate of less than 5% at days 28 and 42; and may be at least as good as, or better than, other marketed ACTs. Pyronaridine-artesunate increases the risk of episodes of abnormally raised ALT. The observational data did not signal an excess of clinically important adverse effects.
Collapse
Affiliation(s)
- Joseph Pryce
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Melissa Taylor
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Tilly Fox
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Paul Hine
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| |
Collapse
|
37
|
Taylor M, Lau D, Proud D. P092 Exploring the association between hand grip strength (HGS) and lung function (FEV1%) in cystic fibrosis: does HGS offer an insight into pulmonary function? J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)00425-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
38
|
Bates A, Naseer MZ, Taylor M, Denham N, Yue A, Das M, Morris GM, Ullah W. UK multi-centre retrospective study of the learning curve and relative performance of the rhythmia high density mapping system for atrial ablation. Europace 2022. [DOI: 10.1093/europace/euac053.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public hospital(s). Main funding source(s): University Hospital Southampton
Background
Rhythmia HDx® is a novel ultra-high density electroanatomical mapping system using an innovative 64 electrode basket catheter. A learning curve is a recognised phenomenon for any new technology and was examined in this study.
Purpose
Comparison of performance, long-term success, and complications using Rhythmia for atrial ablation in the UK.
Methods
Retrospective data collection from three centres across the UK from the introduction of Rhythmia. Patients were matched with controls who had undergone ablation using the well-established Carto3 mapping system. Assessed were: fluoroscopy, radiofrequency ablation and procedure times; acute and long term success, and complications.
Results
253 study patients with 253 controls were included. Significant correlations existed between procedural efficiency metrics and centre experience for de novo atrial fibrillation (AF) ablation (procedure time, Spearman’s ρ = -0.624; ablation time, ρ = -0.795), and de novo atrial flutter (AFlut) ablation (ablation time, ρ = -0.566; fluoroscopy time, ρ = -0.520). No such correlations existed for redo AF, redo AFlut, de novo atrial tachycardia (AT), or redo AT cases. For de novo AF and AFlut, procedural efficiency metrics were significantly improved after 10 procedures in each centre, (procedure time [AF only, p = 0.001], ablation time [AF, p < 0.0005; AFlut p < 0.0005] and fluoroscopy time [AFlut only, p = 0.0022]), and became comparable to controls (Figures 1 and 2). Acute success and long-term success did not see significant improvement with experience but were comparable to the control group. There was no relationship between experience and complications, which were comparable to Carto3 (3.6% in both groups).
Conclusion
A short learning curve exists with the use of Rhythmia HDx for standardised procedures (de novo AF / AFlut). Procedural performance improves and becomes comparable to Carto3 following 10 cases at each centre. Clinical outcomes at 6 and 12 months, and complications are not affected by this learning curve and remain comparable with controls.
Collapse
Affiliation(s)
- A Bates
- University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom of Great Britain & Northern Ireland
| | - MZ Naseer
- University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom of Great Britain & Northern Ireland
| | - M Taylor
- Freeman Hospital, Newcastle-Upon-Tyne, United Kingdom of Great Britain & Northern Ireland
| | - N Denham
- Manchester Royal Infirmary, Manchester, United Kingdom of Great Britain & Northern Ireland
| | - A Yue
- University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom of Great Britain & Northern Ireland
| | - M Das
- Freeman Hospital, Newcastle-Upon-Tyne, United Kingdom of Great Britain & Northern Ireland
| | - GM Morris
- Manchester Royal Infirmary, Manchester, United Kingdom of Great Britain & Northern Ireland
| | - W Ullah
- University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
39
|
Rompolski K, Fojas C, Taylor M, Countess T. How Do Physical Therapists Perceive Anatomy Education? FASEB J 2022. [DOI: 10.1096/fasebj.2022.36.s1.0r724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - Melissa Taylor
- Anatomy and NeurobiologyUniversity of Tennessee Health Sciences CenterMemphisTN
| | | |
Collapse
|
40
|
Taylor M, Nichols RA, Herr M, Loder D. The Effect of Curricular Reform on Gross Anatomy Laboratory Examination Performance: A Retrospective Analysis. FASEB J 2022. [DOI: 10.1096/fasebj.2022.36.s1.00r67] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Melissa Taylor
- Anatomy and NeurobiologyUniversity of Tennessee Health Science CenterMemphisTN
| | | | - Michael Herr
- University of Tennessee Health Science CenterMemphisTN
| | | |
Collapse
|
41
|
Issac H, Keijzers G, Yang IA, Lea J, Taylor M, Moloney C. Development of an Electronic Interdisciplinary Chronic Obstructive Pulmonary Disease (COPD) Proforma (E-ICP) to Improve Interdisciplinary Guideline Adherence in the Emergency Department: Modified Delphi Study. Int J Chron Obstruct Pulmon Dis 2022; 17:1089-1106. [PMID: 35573657 PMCID: PMC9091474 DOI: 10.2147/copd.s358254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2022] [Accepted: 04/11/2022] [Indexed: 11/23/2022] Open
Affiliation(s)
- Hancy Issac
- School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, QLD, Australia
- Centre of Health Research, University of Southern Queensland, Toowoomba, QLD, Australia
- Correspondence: Hancy Issac, School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, QLD, Australia, Email
| | - Gerben Keijzers
- Department of Emergency Medicine, Gold Coast University Hospital, Gold Coast, QLD, Australia
- Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, Australia
- School of Medicine, Griffith University, Gold Coast, QLD, Australia
| | - Ian A Yang
- Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia
- Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia
| | - Jackie Lea
- School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, QLD, Australia
- Centre of Health Research, University of Southern Queensland, Toowoomba, QLD, Australia
| | - Melissa Taylor
- School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, QLD, Australia
- Centre of Health Research, University of Southern Queensland, Toowoomba, QLD, Australia
| | - Clint Moloney
- School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, QLD, Australia
- College of Health and Biomedicine, Nursing and Midwifery, Victoria University, Melbourne, VIC, Australia
- Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia
| |
Collapse
|
42
|
Kopczynska M, Teubner A, Taylor M, Abraham A, Hvas C, Burden S, Carlson G, Lal S. Nutritional autonomy in Short Bowel Syndrome and Intestinal Fistulas. Clin Nutr ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.02.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
43
|
Hong D, Birnbaum A, Steuer C, Taylor M, George T, Lacy J, Wang B, Beca F, Nicacio L, Soumaoro I, Cho M. Efficacy and Safety of Tisotumab Vedotin in Patients with Head and Neck Squamous Cell Carcinoma: Results From a Phase II Cohort. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2021.12.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
44
|
Allali S, Chhun S, Montalembert M, Heilbronner C, Taylor M, Brice J, Elie J, Rignault‐Bricard R, Maciel TT, Chareyre J, Hermine O. Tocilizumab for severe acute chest syndrome in a child with sickle cell disease and dramatically high interleukin-6 values in endotracheal and pleural fluids. Am J Hematol 2022; 97:E81-E83. [PMID: 34874576 DOI: 10.1002/ajh.26433] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2021] [Revised: 12/01/2021] [Accepted: 12/06/2021] [Indexed: 12/31/2022]
Affiliation(s)
- Slimane Allali
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center Necker‐Enfants Malades Hospital, Assistance Publique – Hôpitaux de Paris (AP‐HP), Université de Paris Paris France
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications Université de Paris, Imagine Institute, Inserm U1163 Paris France
- Laboratory of Excellence GR‐Ex Paris France
| | - Stéphanie Chhun
- Laboratory of Immunology Necker‐Enfants Malades Hospital, AP‐HP, Université de Paris, INEM Institute, Inserm U1151 Paris France
| | - Mariane Montalembert
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center Necker‐Enfants Malades Hospital, Assistance Publique – Hôpitaux de Paris (AP‐HP), Université de Paris Paris France
- Laboratory of Excellence GR‐Ex Paris France
| | - Claire Heilbronner
- Department of Pediatric Intensive Care Necker‐Enfants Malades Hospital, AP‐HP, Université de Paris Paris France
| | - Melissa Taylor
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center Necker‐Enfants Malades Hospital, Assistance Publique – Hôpitaux de Paris (AP‐HP), Université de Paris Paris France
- Laboratory of Excellence GR‐Ex Paris France
| | - Joséphine Brice
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center Necker‐Enfants Malades Hospital, Assistance Publique – Hôpitaux de Paris (AP‐HP), Université de Paris Paris France
- Laboratory of Excellence GR‐Ex Paris France
| | - Juliette Elie
- Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center Necker‐Enfants Malades Hospital, Assistance Publique – Hôpitaux de Paris (AP‐HP), Université de Paris Paris France
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications Université de Paris, Imagine Institute, Inserm U1163 Paris France
| | - Rachel Rignault‐Bricard
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications Université de Paris, Imagine Institute, Inserm U1163 Paris France
- Laboratory of Excellence GR‐Ex Paris France
| | - Thiago Trovati Maciel
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications Université de Paris, Imagine Institute, Inserm U1163 Paris France
- Laboratory of Excellence GR‐Ex Paris France
| | - Judith Chareyre
- Department of Pediatric Intensive Care Necker‐Enfants Malades Hospital, AP‐HP, Université de Paris Paris France
| | - Olivier Hermine
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications Université de Paris, Imagine Institute, Inserm U1163 Paris France
- Laboratory of Excellence GR‐Ex Paris France
- Department of Hematology Necker‐Enfants Malades Hospital, AP‐HP, Université de Paris Paris France
| |
Collapse
|
45
|
Taylor M, Thomas R, Oliver S, Garner P. Community views on mass drug administration for filariasis: a qualitative evidence synthesis. Cochrane Database Syst Rev 2022; 2:CD013638. [PMID: 35174482 PMCID: PMC8851040 DOI: 10.1002/14651858.cd013638.pub2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
BACKGROUND The World Health Organization (WHO) recommends mass drug administration (MDA), giving a drug at regular intervals to a whole population, as part of the strategy for several disease control programmes in low- and middle-income countries. MDA is currently WHO policy for areas endemic with lymphatic filariasis, which is a parasitic disease that can result in swollen limbs and disability. The success depends on communities adhering to the drugs given, and this will be influenced by the perception of the drug, the programme, and those delivering it. OBJECTIVES: To synthesize qualitative research evidence about community experience with, and understanding and perception of, MDA programmes for lymphatic filariasis. To explore whether programme design and delivery influence the community experience identified in the analysis. SEARCH METHODS We searched CENTRAL, MEDLINE, Embase, and seven other databases up to 8 April 2021, together with reference checking, citation searching, and contact with study authors to identify additional studies. SELECTION CRITERIA This review synthesized qualitative research and mixed-methods studies when it was possible to extract qualitative data. Eligible studies explored community experiences, perceptions, or attitudes towards MDA programmes for lymphatic filariasis in any country, conducted between 2000 and 2019. DATA COLLECTION AND ANALYSIS: We extracted data on study design including: authors, aims, participants, methods, and qualitative data collection methods. We also described programme delivery factors including: country, urban or rural setting, endemicity, drug regimen, rounds of MDA received at the time of the study, who delivered the drugs, how the drugs were delivered, use of health education, and sensitization and adherence monitoring. We conducted a thematic analysis and developed codes inductively using ATLAS.ti software. We examined codes for underlying ideas, connections, and interpretations and, from this, generated analytical themes. We assessed the confidence in the findings using the GRADE-CERQual approach, and produced a conceptual model to display our findings. MAIN RESULTS: From 902 results identified in the search, 29 studies met our inclusion criteria. The studies covered a broad range of countries in Africa, South-East Asia, and South America, and explored the views and experiences of community members and community drug distributors in low-income countries endemic for lymphatic filariasis. Four themes emerged. People weigh up benefits and harms before participating. People understand the potential benefits in terms of relief of suffering, stigma, and avoiding costs (high confidence); however, these theoretical benefits do not always mesh with their experiences (high confidence). In particular, adverse effects are frightening and unwelcome (high confidence); and these effects are amplified through rumour and social media (moderate confidence). Many people are suspicious of MDA programmes. When people lack a scientific explanation for the programme and their experiences of it, they often develop social explanations instead. These are largely shaped on the historical backdrop and level of trust people have in relevant authority figures (high confidence), although some have unwavering faith in their government and, by extension, the programme (moderate confidence). Programmes expect compliance, and this can become coercive and blaming. Health workers and community members stigmatize non-compliance, which can become coercive (moderate confidence), so communities may appear to comply publicly, but privately reject treatment (moderate confidence). Community distributors are often not respected or valued. They have little authority (moderate confidence), and the behaviour of some distributors damages the MDA programme's reputation (high confidence). Communities want information about programmes to help make decisions about participation, but drug distributors are not sufficiently informed, or skilled in this communication (high confidence). We intended to assess whether programme designs influenced communities' perceptions of the programme and decision to adhere but were unable to do so as few studies adequately reported the design and implementation of the local programme. We have moderate to high confidence in the evidence contributing to the review themes and subthemes. AUTHORS' CONCLUSIONS Adherence with MDA for filariasis is influenced by individual direct experience of benefit and harm; social influences in the community; political influences and their relationship to government; and historical influences. Fear of adverse effects was frequently described and this appears to be particularly important for communities. When views were negative, we were surprised by the strength of feeling expressed. Enthusiasm for these schemes as a strategy in global policy needs debate in the light of these findings.
Collapse
Affiliation(s)
- Melissa Taylor
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Rebecca Thomas
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Sandy Oliver
- EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London, London, UK
- Africa Centre for Evidence, Faculty of Humanities, University of Johannesburg, Johannesburg, South Africa
| | - Paul Garner
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
- Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
| |
Collapse
|
46
|
Hardy M, Taylor M, Merchant M, Mackay R. FLASH Modalities Track (Oral Presentations) CAN PROTON FLASH BEAMS BE USED SAFELY WITH EXISTING SHIELDING? Phys Med 2022. [DOI: 10.1016/s1120-1797(22)01477-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
47
|
Issac H, Moloney C, Taylor M, Lea J. Mapping of Modifiable Factors with Interdisciplinary Chronic Obstructive Pulmonary Disease (COPD) Guidelines Adherence to the Theoretical Domains Framework: A Systematic Review. J Multidiscip Healthc 2022; 15:47-79. [PMID: 35046662 PMCID: PMC8759995 DOI: 10.2147/jmdh.s343277] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Accepted: 12/16/2021] [Indexed: 12/26/2022] Open
Abstract
BACKGROUND COPD guidelines non-concordance is a challenge frequently highlighted by respiratory experts. Despite the provision of comprehensive evidence-based national and international guidelines, the COPD burden to frontline healthcare services has increased in the last decade. Suboptimal guidelines concordance can be disruptive to health-related quality of life (HRQoL), hastening pulmonary function decline and surging overall morbidity and mortality. A lack of concordance with guidelines has created an escalating economic burden on health-care systems. Identifying interdisciplinary interventions to facilitate improved adherence to guidelines may significantly reduce re-admissions, enhance HRQoL amongst patients and their families, and facilitate economic efficiency. MATERIALS AND METHODS This review adhered to the Joanna Briggs Institute (JBI) methodology for mixed methods systematic reviews and the PRISMA ScR reporting guidelines. Two independent reviewers screened abstracts and full text articles in consonance with inclusion criteria. The convergent integrative JBI method collated quantitative, qualitative and mixed methods studies from nine databases. JBI critical appraisal tools were utilised to assess the quality of research papers. The theoretical domains framework (TDF) along with a specifically developed COPD data extraction tool were adopted as a priori to collect and collate data. Identified barriers and corresponding clinical behavioural change solutions were categorised using TDF domains and behavior change wheel (BCW) to provide future research and implementation recommendations. RESULTS Searches returned 1068 studies from which 37 studies were included (see Figure 1). COPD recommendations identified to be discordant with clinical practice included initiating non-invasive ventilation, over- or under-prescription of corticosteroids and antibiotics, and a lack of discharging patients with a smoking cessation plan or pulmonary rehabilitation. TDF domains with highest frequency scores were knowledge, environmental resources, and clinical behaviour regulation. Electronic order sets/digital proforma with guideline resources at point of care and easily accessible digital community referrals to target both pharmacological and non-pharmacological management appear to be a solution to improve concordance. CONCLUSION Implementation of consistent quality improvement intervention within hospitals for patients with COPD may exclude any implementation gap and prevent readmissions. Electronic proformas with digital referrals will assist with future evaluation audits to prioritise and target interventions to improve guidelines concordance. ETHICS AND DISSEMINATION Ethical approval is not required, and results dissemination will occur through peer-reviewed publication. PROSPERO REGISTRATION NUMBER CRD42020156267.
Collapse
Affiliation(s)
- Hancy Issac
- School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, Australia
- Centre for Health Research, University of Southern Queensland, Toowoomba, Australia
| | - Clint Moloney
- School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, Australia
- College of Health and Biomedicine, Nursing and Midwifery, Victoria University, Melbourne, Australia
- Clinical Community Health and Wellbeing, Research Institute for Health and Sport, Victoria University, Melbourne, Australia
| | - Melissa Taylor
- School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, Australia
- Centre for Health Research, University of Southern Queensland, Toowoomba, Australia
| | - Jackie Lea
- School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, Australia
- Centre for Health Research, University of Southern Queensland, Toowoomba, Australia
| |
Collapse
|
48
|
Pustz J, Shrestha S, Newsky S, Taylor M, Fowler L, Van Handel M, Lingwall C, Stopka TJ. Opioid-Involved Overdose Vulnerability in Wyoming: Measuring Risk in a Rural Environment. Subst Use Misuse 2022; 57:1720-1731. [PMID: 35975873 DOI: 10.1080/10826084.2022.2112229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
Abstract
BACKGROUND Between 2009 and 2019 opioid-involved fatal overdose rates increased by 45% and the average opioid dispensing rate in Wyoming was higher than the national average. The opioid crisis is shaped by a complex set of socioeconomic, geopolitical, and health-related variables. We conducted a vulnerability assessment to identify Wyoming counties at higher risk of opioid-related harm, factors associated with this risk, and areas in need of overdose treatment access to inform priority responses. METHODS We compiled 2016 to 2018 county-level aggregated and de-identified data. We created risk maps and ran spatial analyses in a geographic information system to depict the spatial distribution of overdose-related measures. We used addresses of opioid treatment programs and buprenorphine providers to develop drive-time maps and ran 2-step floating catchment area analyses to measure accessibility to treatment. We used a straightforward and replicable weighted ranks approach to calculate final county vulnerability scores and rankings from most to least vulnerable. FINDINGS We found Hot Springs, Carbon, Natrona, Fremont, and Sweetwater Counties to be most vulnerable to opioid-involved overdose fatalities. Opioid prescribing rates were highest in Hot Springs County (97 per 100 persons), almost two times the national average (51 per 100 persons). Statewide, there were over 90 buprenorphine-waivered providers, however accessibility to these clinicians was limited to urban centers. Most individuals lived further than a four-hour round-trip drive to the nearest methadone treatment program. CONCLUSIONS Identifying Wyoming counties with high opioid overdose vulnerabilities and limited access to overdose treatment can inform public health and harm reduction responses.
Collapse
Affiliation(s)
- Jennifer Pustz
- Department of Public Health & Community Medicine, Tufts University School of Medicine, Boston, MA
| | - Shikhar Shrestha
- Department of Public Health & Community Medicine, Tufts University School of Medicine, Boston, MA
| | | | - Melissa Taylor
- Public Health Division, Wyoming Department of Health, Cheyenne, WY
| | - Leslie Fowler
- Public Health Division, Wyoming Department of Health, Cheyenne, WY
| | | | - Cailyn Lingwall
- Council of State and Territorial Epidemiologists, Atlanta, GA
| | - Thomas J Stopka
- Department of Public Health & Community Medicine, Tufts University School of Medicine, Boston, MA
| |
Collapse
|
49
|
Ferkh A, Tjahjadi C, Geenty P, Stefani L, Boyd A, Richards D, Mollee P, Korczyk D, Taylor M, Kwok F, Kizana E, Ng A, Thomas L. Echocardiographic Deep Phenotyping of Hypertrophic Cardiomyopathies: Amyloid, Anderson-Fabry and Hypertensive Heart Disease. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
50
|
Tulleners T, Taylor M, Campbell C. Peer group clinical supervision for community health nurses: Perspectives from an interpretive hermeneutic study. J Nurs Manag 2021; 30:684-693. [PMID: 34904765 DOI: 10.1111/jonm.13535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2021] [Revised: 11/16/2021] [Accepted: 12/09/2021] [Indexed: 11/28/2022]
Abstract
AIM To explore the lived experience of utilizing peer group supervision in practice for community health nurses. BACKGROUND Community health nursing is an autonomous and challenging role where quality clinical supervision has benefits for the registered nurse. The structured New Zealand Coaching and Mentoring model of peer group supervision provides the foundation for this research. METHOD An interpretative hermeneutic study explored the experience of peer group supervision in a regional health service in Australia. Qualitative in-depth interviews were conducted with all levels of nursing staff to gain an understanding of their experience of peer group supervision. RESULTS Data interpretation through hermeneutic analysis revealed the value and professional sustenance gained by participants. Identified game changers include adherence to rules and the influence of group dynamics. These areas were found to impact the quality of supervision. CONCLUSIONS This research provides different perspectives of peer group supervision that shares the experience of staff immersed in the process. Peer group supervision yields benefits for community health nurses; however, the research has implications for practice. IMPLICATIONS FOR NURSING MANAGEMENT Nurse managers require information when making key decisions regarding workplace implementation. Effective supervision is only possible when balance between benefits and game changers are achieved.
Collapse
Affiliation(s)
- Tracey Tulleners
- School of Nursing and Midwifery, University of Southern Queensland, Ipswich, Australia
| | - Melissa Taylor
- School of Nursing and Midwifery, University of Southern Queensland, Ipswich, Australia
| | - Christina Campbell
- School of Health and Wellbeing, University of Southern Queensland, Ipswich, Australia
| |
Collapse
|